-
-
This time is peak time to do worship ,,
#BioAsia2018 in Asia the CHYREN is present Rs 3,695 pic.twitter.com/J8VDh3Rl8B
-
That's all folks! On behalf of all the enablers, Sponsors, partners, supporters and organizers of
#BioAsia2018 we'd like to thank you for an overwhelming response and participation. Have a healthy and progressive year. See you again in#Hyderabad in 2019.pic.twitter.com/uAMsILqMgE
-
#India’s#healthcare market is filled with opportunities. The Dutch#LifeSciencesAndHealth sector is exploring#partnership to#InnovateInIndia. Together#NLIndia can tackle joint challenges with smart solutions.#MakeInIndia#InnovateTogether#Innovation#BioAsia2018#Vaccinespic.twitter.com/si295U2dJk -
Minister
@KTRTRS met with Sanat Chattopadhyay, President, Merck Manufacturing Division (MMD) on the sidelines of#BioAsia2018 in Hyderabad today. pic.twitter.com/2QeJBmEWaX
-
@KTRTRS sir out team from vja Kluniversity came to#bioasia2018 we tried hard to have a pic with u but you were busy and we dnt have a pic pls retweet and make us happy sir@trspartyonline#trs@ntdailyonline @MinIT_Telangana@TelanganaCMOpic.twitter.com/D1zKbE8AIA
Prikaži ovu nit -
#BioAsia2018 - new drug discovery and innovation debate. BioAsia: Experts call on India to step up in drug discovery, innovation https://telanganatoday.com/bioasia-experts-india-step-drug-discovery-innovation … via@TelanganaToday -
Minister of Commerce, Suresh Prabhu talking about the future of pharma industry in India at
#BioAsia2018 pic.twitter.com/CGcXzdOdmD
-
Minister
@KTRTRS met with Udit Batra, CEO, Life Sciences, Merck KGaA, Germany on the sidelines of#BioAsia2018 at HICC in Hyderabad today. pic.twitter.com/lmp35Wu0p1
-
Takeaways from @BioAsia2018 Consultative policy formulation, Predictable regulatory framework, Collaborative R&D, Frugal Innovation, Focus on new technologies & Competent IP protection mechanism are the key pointers for India to emerge as leader in Life sciences
#BioAsia2018 pic.twitter.com/FYkCgSYDT2
-
At
#BioAsia2018.#Deloitte being the proud Knowledge Partner of the unique platform to connect and discuss NextGen ideas and innovations in LifeSciences pic.twitter.com/xE4xFN4JnL
-
IQ4I Research & Consultancy is proud to participate @BioAsia2018 as exhibitor in startup & business partnering
#BioAsia2018 -
Please visit us at H-14 Startup pavilion of @BioAsia2018, 22-24-Feb, Hyderabad and learn how we can help Biotech/Pharma/Medical device/IT-Healthcare firms in identifying the market opportunities with our best-in-class market intelligence and consulting services.
#BioAsia2018 -
Hon’ble Minister Shri
@KTRTRS is addressing the gathering at#BioAsia2018 pic.twitter.com/02jEpzVZaf
-
Team SA at the South African exhibition stand at
#BioAsia2018 @BioAsia2018#BioAfricaConventionpic.twitter.com/58BArJtSiA
-
Our aim is to double the size of Telangana life sciences ecosystem to $100 Billion to create 4 lakh new jobs mostly in manufacturing Hyderabad Pharma City & Medical devices park along with Genome Valley 2.0 will be the key engines
#BioAsia2018 https://economictimes.indiatimes.com/news/science/telangana-aims-to-double-size-of-life-sciences-sector-to-100-bn/articleshow/63034969.cms … -
IT & Industries Minister
@KTRTRS having a fireside chat with Hon’ble Union Minister@CimGOI@sureshpprabhu at#BioAsia2018 in Hyderabad today. pic.twitter.com/4sDlYUbJXu
-
How
#pharma and#HealthTech companies can work together-a panel discussion begins at#BioAsia2018 pic.twitter.com/c1ybEsrFzS
-
Novartis working towards changing the practice of medicine.
@saradhye talks about meaningful life changing innovations.#BioAsia2018@Svepea@mekatas@iyervaishali@JawedsThoughts@NGthinkspic.twitter.com/vwqWdF8KBt
-
A new incubator will be set up in Genome Valley, Shamirpet to work on new vaccine discovery and the dynamic areas such as immunotherapy, nano sciences & nanotechnology Telangana produces 1/3rd of world vaccines today
#BioAsia2018 https://telanganatoday.com/telangana-is-now-a-vaccine-hub-says-ktr …
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.